Disclaimers Do Not Remedy Content Violations – FDA Warning Letter

Providing disclaimers for material that promotes an uncleared or unapproved use does not remedy content violations, FDA's device center Promotion and Policy Staff emphasize in a Nov. 5 letter to Diomed

More from Archive

More from Medtech Insight